ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
chemoradiotherapychemotherapyimmunotherapy
esophageal cancer, nimotuzumab, chemoradiotherapy, chemotherapy, immunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 836922
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.